检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (vol 14, 1021535, 2023)

Daniel Morales-Cano,Jose Luis Izquierdo-Garcia,Bianca Barreira,Sergio Esquivel-Ruiz,Maria Callejo,Rachele Pandolfi,Palmira Villa-Valverde,Ignacio Rodriguez,Angel Cogolludo,Jesus Ruiz-Cabello,Francisco Perez-Vizcaino,Laura Moreno

FRONTIERS IN PHARMACOLOGY（2023）

引用 0|浏览0
暂无评分
关键词
pulmonary hypertension, antiproliferative, metabolomics, combination therapy, right ventricle
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要